Variant report
Variant | esv3362627 |
---|---|
Chromosome Location | chr17:66960307-66962305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183884157 | chr17:66960321-66960322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74318243 | chr17:66960350-66960351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73364083 | chr17:66960356-66960357 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs538349991 | chr17:66960426-66960427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572045859 | chr17:66960446-66960447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550116673 | chr17:66960459-66960460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188365332 | chr17:66960541-66960542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181814780 | chr17:66960630-66960631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185576778 | chr17:66960681-66960682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs62087828 | chr17:66960696-66960697 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570018016 | chr17:66960796-66960797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75864821 | chr17:66960806-66960807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140823065 | chr17:66960813-66960814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12945526 | chr17:66960822-66960823 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs12940203 | chr17:66960839-66960840 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs12940209 | chr17:66960843-66960844 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs570829810 | chr17:66960923-66960924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536679675 | chr17:66960936-66960937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373953849 | chr17:66960949-66960950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375763201 | chr17:66960954-66960955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570309744 | chr17:66960959-66960960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373842738 | chr17:66960960-66960961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528297858 | chr17:66960963-66960964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548263425 | chr17:66961124-66961125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569781043 | chr17:66961185-66961186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537172003 | chr17:66961222-66961223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555897216 | chr17:66961233-66961234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577775168 | chr17:66961258-66961259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs202012861 | chr17:66961259-66961260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12936488 | chr17:66961293-66961294 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs12950368 | chr17:66961326-66961327 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs571923802 | chr17:66961339-66961340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576022548 | chr17:66961366-66961367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190234840 | chr17:66961384-66961385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181890095 | chr17:66961385-66961386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79284837 | chr17:66961386-66961387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114910254 | chr17:66961427-66961428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377069017 | chr17:66961448-66961449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565328754 | chr17:66961455-66961456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113805507 | chr17:66961578-66961579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573860120 | chr17:66961585-66961586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542795421 | chr17:66961673-66961674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532788771 | chr17:66961726-66961727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541342065 | chr17:66961762-66961763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560029623 | chr17:66961847-66961848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117777292 | chr17:66961892-66961893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548152723 | chr17:66961935-66961936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530943441 | chr17:66961943-66961944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369773690 | chr17:66961963-66961964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530875422 | chr17:66961964-66961965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Congenital generalized hypertrichosis terminalis | 19463983 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Gingival hyperplasia | 19463983 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16417655 | CNVD |
Breast cancer | 21045282 | CNVD |
Epilepsy | 22083797 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Honadal dysgenesis | 21408189 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:66957600-66960400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr17:66957800-66960400 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr17:66958600-66965000 | Weak transcription | Fetal Brain Male | brain |
4 | chr17:66960400-66960600 | Enhancers | Adipose Nuclei | Adipose |
5 | chr17:66960400-66960800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr17:66960800-66969200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |